Overexpression of intercellular adhesion molecule-1 (ICAM-1) in pancreatic adenocarcinoma in comparison with normal pancreas

Pancreas

Volumn 14, Issue 2, 1997, Pages 181-186

  Shimoyama, Shouji ^a,b   Gansauge, Frank ^a   Gansauge, Susanne ^a   Widmaier, Uwe ^a   Oohara, Takeshi ^b   Beger, Hans G ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cell cell adhesion; Immunohistochemistry; In situ hybridization; Intercellular adhesion molecules; Pancreatic adenocarcinoma

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERCELLULAR ADHESION MOLECULE 2; INTERCELLULAR ADHESION MOLECULE 3; MESSENGER RNA; MONOCLONAL ANTIBODY;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA PROBE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STAINING;

EID: 0031056833     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199703000-00011     Document Type: Article

References (34)

1. Dustin ML, Springer TA. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol 1991;9:27-66.
2. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993;9:541-73.
3. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
4. Springer TA. The sensation and regulation of interactions with the extracellular environment: the cell biology of lymphocyte adhesion receptors. Annu Rev Cell Biol 1990;6:359-402.
5. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-54.
6. de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 1991;174:253-67.
7. de Fougerolles AR, Springer TA. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med 1992; 175:185-90.
8. Fawcett J, Holness CLL, Needham LA, et al. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 1992;360:481-4.
9. Malizia G, Calabrese A, Cottone M, et al. Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology 1991;100:150-9.
10. Lisby S, Ralfkiaer E, Rothlein R, Vejlsgaard GL. Intercellular adhesion molecule-I (ICAM-I) expression correlated to inflammation. Br J Dermatol 1989;120:479-84.
11. Stauder R, Greil R, Schulz TF, et al. Expression of leukocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour. Clin Exp Immunol 1989; 77:234-8.
12. Hawley RG, Wang MH, Fong AZC, Hawley TS. Association between ICAM-1 expression and metastatic capacity of murine B-cell hybridomas. Clin Exp Metastasis 1993;11:213-26.
13. Johnson JP, Stade BG, Holzmann B, Schwäble W, Riethmüller G. De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 1989;86:641-4.
14. Natali P, Nicotra MR, Cavaliere R, et al. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res 1990;50:1271-8.
15. Koyama S, Ebihara T, Fukao K. Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma. J Cancer Res Clin Oncol 1992;118:609-14.
16. Vogetseder W, Feichtinger H, Schulz TF, et al. Expression of 7F7-antigen, a human adhesion molecule identical to intercellular adhesion molecule-1 (ICAM-1) in human carcinomas and their stromal fibroblasts. Int J Cancer 1989;43:768-73.
17. Schwäble W, Kerlin M, Büschenfelde KHM, Dippold W. De novo expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in pancreas cancer. Int J Cancer 1993;53:328-33.
18. Hermanek P, Sobin LH, eds. TNM classification of malignant tumours. New York: Springer Verlag, 1987.
19. Springer TA, Dustin ML, Kishimoto TK, Marlin SD. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol 1987;45:223-52.
20. Warford A. In situ hybridisation: a new tool in pathology. Med Lab Sci 1988;45:381-94.
21. Simmons D, Makgoba MW, Seed B, ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature 1988;331:624-7.
22. Staunton DE, Marlin SD, Stratowa C, Dustin M, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988;52:925-33.
23. Adams DH, Hubscher SG, Shaw J, Rothlein R, Neuberger JM. Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet 1989;2:1122-5.
24. Tsuchiya R, Oribe T, Noda T. Size of the tumor and other factors influencing prognosis of carcinoma of the head of the pancreas. Am J Gastroenterol 1985;80:459-62.
25. Shimoyama S, Gansauge F, Gansauge S, Oohara T, Beger HG. Altered expression of extracellular matrix molecules and their receptors in chronic pancreatitis and pancreatic adenocarcinoma in comparison with normal pancreas. Int J Pancreatol 1995;18:227-34.
26. Hall PA, Coates P, Lemoine NR, Horton MA. Characterization of integrin chains in normal and neoplastic human pancreas. J Pathol 1991;165:33-41.
27. De Baetselier P, Roos E, Brys L, Remels L, Feldman M. Generation of invasive and metastatic variants of a non-metastatic T-cell lymphoma by in vivo fusion with normal host cells. Int J Cancer 1984;34:731-8.
28. Orr FW, Mokashi S. Effect of leukocyte activation on the formation of heterotypic tumor-cell aggregates in vivo. Int J Cancer 1985;35:101-6.
29. Gatanaga T, Hwang C, Kohr W, et al. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc Natl Acad Sci USA 1990;87:8781-4.
30. Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt R, Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α. J Immunol 1991;147:4398-401.
31. Roep BO, Heidenthal E, de Vries RRP, Kolb H, Martin S. Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus. Lancet 1994;343:1590-3.
32. Giavazzi R, Chirivi RGS, Garofalo A, et al. Soluble intercellular adhesion molecule 1 is released by human melanoma cells and is associated with tumor growth in nude mice. Cancer Res 1992;52: 2628-30.
33. Damle NK, Klussman K, Aruffo A. Intercellular adhesion molecule-2, a second counter-receptor for CD11a/CD18 (leukocyte function-associated antigen-1), provides a costimulatory signal for T-cell receptor-initiated activation of human T cells. J Immunol 1992;148:665-71.
34. Campanero MR, del Pozo MA, Arroyo AG, et al. ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway. J Cell Biol 1993;123:1007-16.